semaglutide and addiction Ozempic maker Novo Nordisk says it will study drug's effects on alcohol consumption but isn't focused on Patients are already asking about

Aging of the immune system: focus on inflammation and vaccination

At HMR, our goal is to empower you with the tools, knowledge, and skills to be successful in achieving your weight and health goals

Footnotes Disclosure: SK has a sponsored research agreement with Janssen Pharmaceuticals Inc., serves on a scientific advisory board for Altimmune, and has served as a consultant for Eli Lilly and B2M Medical

In Phase 2 trials, retatrutide produced approximately 24% mean weight loss at 48 weeks at 12 mg, compared with about 22.5% for tirzepatide at 15 mg in the SURMOUNT-1 trial though direct head-to-head data is not yet available